THIOLA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Thiola, and when can generic versions of Thiola launch?
Thiola is a drug marketed by Mission Pharma and Mission Pharmacal and is included in two NDAs. There is one patent protecting this drug.
The generic ingredient in THIOLA is tiopronin. There are three drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the tiopronin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Thiola
A generic version of THIOLA was approved as tiopronin by TEVA PHARMS USA INC on April 26th, 2021.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for THIOLA?
- What are the global sales for THIOLA?
- What is Average Wholesale Price for THIOLA?
Summary for THIOLA
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 97 |
| Clinical Trials: | 1 |
| Patent Applications: | 2,864 |
| Drug Prices: | Drug price information for THIOLA |
| What excipients (inactive ingredients) are in THIOLA? | THIOLA excipients list |
| DailyMed Link: | THIOLA at DailyMed |
Recent Clinical Trials for THIOLA
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Florida | Phase 2 |
| E. Sander Connolly | Phase 2 |
| Food and Drug Administration (FDA) | Phase 2 |
Pharmacology for THIOLA
| Drug Class | Reducing and Complexing Thiol |
| Mechanism of Action | Cystine Disulfide Reduction |
US Patents and Regulatory Information for THIOLA
THIOLA is protected by zero US patents and one FDA Regulatory Exclusivity.
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mission Pharma | THIOLA | tiopronin | TABLET;ORAL | 019569-001 | Aug 11, 1988 | AB | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Mission Pharmacal | THIOLA EC | tiopronin | TABLET, DELAYED RELEASE;ORAL | 211843-002 | Jun 28, 2019 | AB | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Mission Pharmacal | THIOLA EC | tiopronin | TABLET, DELAYED RELEASE;ORAL | 211843-001 | Jun 28, 2019 | AB | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Mission Pharmacal | THIOLA EC | tiopronin | TABLET, DELAYED RELEASE;ORAL | 211843-001 | Jun 28, 2019 | AB | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Mission Pharmacal | THIOLA EC | tiopronin | TABLET, DELAYED RELEASE;ORAL | 211843-002 | Jun 28, 2019 | AB | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
